An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers.
about
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines.Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinationsSingle dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strainsImmune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.Pandemic influenza vaccination elicits influenza-specific CD4+ Th1-cell responses in hypogammaglobulinaemic patients: four case reports.Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.Differences in pandemic influenza vaccination policies for pregnant women in EuropeEffect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing.Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion.Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults.Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized trial in Japanese children aged 6 months to 17 years.The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older personsSafety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinationsMulti-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccineSafety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort studyLong-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized study in adults aged 18-60 years and older.High Prevalence of Humoral and Cellular Immunity to Influenza Viruses in Preschool Children Living in Addis Ababa, Ethiopia.Community-Based Risk Communication Survey: Risk Prevention Behaviors in Communities during the H1N1 crisis, 2010.Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes.Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adultsImmunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy populationLongevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccinesLive Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils.From discovery to licensure, the Adjuvant System story.Low response to a monovalent inactivated unadjuvanted influenza A (H1N1) pdm09 vaccine in pediatricians of a general hospital in Japan.Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination.Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy.A(H1N1)pdm09 vaccination of health care workers: improved immune responses in low responders following revaccination.Augmented CD4 T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
P2860
Q30353675-271AB40D-D340-4AED-995E-3FB28B72875EQ30360768-BC728647-D7EE-4BC1-8A11-E39F59F9D695Q30369098-3B4ED9CA-8F01-4F19-8926-261EED5BB285Q30374968-0591590C-ADFE-4FE1-B345-ECA57F21D3FDQ30381864-39C13489-E15B-4C38-A69E-43B0A9DB1051Q30401158-63FF983A-C4A7-425E-B89C-2C5F9EC9F217Q30407050-D6238698-6CD0-4BCA-8CD0-6EB90F08E74DQ30408457-4EEACDD8-ED03-4DF7-85EB-480046CA47BCQ30411896-CC705797-6B6E-4353-BE04-CEAD15342A59Q30413695-3D688E93-D85C-4F5B-94DB-6EC8D47149D8Q30414384-03F14C28-CBC5-44EB-8AC1-C6AC4B3C3CCDQ30415263-033CEAF3-ADC8-4C63-994C-FC7DC76524AFQ30417273-544EC959-FEB7-4450-B53D-11483E81D0E5Q30419062-C85886AE-0234-4E3A-8FB6-88EE4162B35FQ30419240-6A1C13AE-07FF-451A-B343-9B3B659FABF1Q30426674-9255BDF4-66DD-4A82-8D64-9E333E4A5DC7Q30426869-D00E3E8F-825E-49D2-B38C-673C66FECC40Q30429185-A5C45A31-1AB0-4F42-9845-E778CDFCE5E3Q33629114-0D3E610D-15CC-4508-9B67-18BA11E7E436Q33782511-2F6376FF-6FDF-49C1-A932-29B31EC14608Q34199805-7C3FC8F4-0AA1-4DF8-8EA2-9024158208C4Q34729188-5B9EEF8A-2A09-4317-A596-05314C0A45DDQ35191251-E039D242-F4C7-4D06-A3AA-E1FE6EB42E92Q35531941-45C7CC79-D5E0-427F-B640-D17CA7CD789AQ36629013-B103CD1A-3FD2-43FD-9A99-1C4C3573159EQ37161924-E73EFBF0-138D-4E93-A740-3B8050E3CFA4Q37619140-86C04D44-0F7A-4B91-A0AC-626B781232BAQ43171863-151D3453-6320-4CBC-8B6C-F86334AEF94EQ47136777-02E18523-B45B-422C-8A5D-9370F4F270E7Q47569520-679AC9CD-79F3-4CEC-B012-2ACF09E00D95Q50938543-A004C461-2306-4B8C-A033-788F6BFDD3CDQ57093922-1939DCF2-7977-4F42-B724-FD2CEA8155A0
P2860
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An adjuvanted pandemic influen ...... ection in health care workers.
@ast
An adjuvanted pandemic influen ...... ection in health care workers.
@en
type
label
An adjuvanted pandemic influen ...... ection in health care workers.
@ast
An adjuvanted pandemic influen ...... ection in health care workers.
@en
prefLabel
An adjuvanted pandemic influen ...... ection in health care workers.
@ast
An adjuvanted pandemic influen ...... ection in health care workers.
@en
P2093
P1433
P1476
An adjuvanted pandemic influen ...... ection in health care workers.
@en
P2093
Abdullah S Madhun
Asne Jul-Larsen
Diane Major
Gabriel Pedersen
Haakon Sjursen
Ingrid Smith
Jane Kristin Nøstbakken
Kristin Mohn
Mona Nilsen
P304
P356
10.1016/J.VACCINE.2010.10.038
P407
P577
2010-10-27T00:00:00Z